A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
EvolveImmune United, Inc
EvolveImmune United, Inc
AstraZeneca
Sumitomo Pharma America, Inc.
LigaChem Biosciences, Inc.
HRYZ Biotech Co.